This inventor holds 1 USPTO granted patent. Top assignee: Innogenetics N.v.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: An Van Den Bulcke: Innovator in Biopolymer Medicaments
Introduction
An Van Den Bulcke is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biopolymer medicaments, particularly through his innovative patent. His work focuses on the development of advanced materials that can be utilized in medical applications.
Latest Patents
An Van Den Bulcke holds a patent for "Medicaments based on polymers composed of methacrylamide-modified gelatin." This invention relates to a composition that includes a biopolymer matrix made from cross-linked vinyl-derivatives of gelatin or co-polymerized methacrylamide modified gelatin with vinyl-modified polysaccharides. The patent emphasizes the use of polysaccharides such as dextran or xanthan. Additionally, it describes a wound dressing or controlled release device that incorporates this biopolymer matrix, which can be formed into various structures like hydrated films, foams, or microbeads. The design aims to maintain optimal humidity levels for therapeutic purposes.
Career Highlights
An Van Den Bulcke is associated with Innogenetics N.V., where he has contributed to the advancement of biopolymer technologies. His work has been instrumental in developing innovative solutions for medical applications, particularly in wound care and drug delivery systems.
Collaborations
An has collaborated with notable colleagues such as Etienne Honore Schacht and Bernard Delaey. Their combined expertise has fostered advancements in the field of biopolymer medicaments.
Conclusion
An Van Den Bulcke is a distinguished inventor whose work in biopolymer medicaments has the potential to significantly impact medical treatments. His innovative approaches and collaborations continue to drive advancements in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
